These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 16314608)

  • 1. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.
    Ironson G; O'Cleirigh C; Fletcher MA; Laurenceau JP; Balbin E; Klimas N; Schneiderman N; Solomon G
    Psychosom Med; 2005; 67(6):1013-21. PubMed ID: 16314608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial and Neurohormonal Predictors of HIV Disease Progression (CD4 Cells and Viral Load): A 4 Year Prospective Study.
    Ironson G; O'Cleirigh C; Kumar M; Kaplan L; Balbin E; Kelsch CB; Fletcher MA; Schneiderman N
    AIDS Behav; 2015 Aug; 19(8):1388-97. PubMed ID: 25234251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conscientiousness predicts disease progression (CD4 number and viral load) in people living with HIV.
    O'Cleirigh C; Ironson G; Weiss A; Costa PT
    Health Psychol; 2007 Jul; 26(4):473-80. PubMed ID: 17605567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral treatment adherence as a mediating factor between psychosocial variables and HIV viral load.
    Attonito J; Dévieux JG; Lerner BD; Hospital MM; Rosenberg R
    J Assoc Nurses AIDS Care; 2014; 25(6):626-37. PubMed ID: 25305029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with 10 years of continuous viral load suppression on HAART.
    Bello KJ; Mesner O; O'Bryan TA; Won SH; Lalani T; Ganesan A; Agan BK; Okulicz JF
    BMC Infect Dis; 2016 Jul; 16():351. PubMed ID: 27449671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
    Seyoum A; Ndlovu P; Temesgen Z
    AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus.
    Shingadia D; Viani RM; Yogev R; Binns H; Dankner WM; Spector SA; Chadwick EG
    Pediatrics; 2000 Jun; 105(6):E80. PubMed ID: 10835093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
    J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spiritual coping predicts CD4-cell preservation and undetectable viral load over four years.
    Kremer H; Ironson G; Kaplan L; Stuetzele R; Baker N; Fletcher MA
    AIDS Care; 2015; 27(1):71-9. PubMed ID: 25297848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies.
    Martín JC; Soriano V; Jiménez-Nácher I; Martínez P; González-Lahoz J
    Clin Microbiol Infect; 2001 Dec; 7(12):678-81. PubMed ID: 11843909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS.
    Leserman J; Petitto JM; Golden RN; Gaynes BN; Gu H; Perkins DO; Silva SG; Folds JD; Evans DL
    Am J Psychiatry; 2000 Aug; 157(8):1221-8. PubMed ID: 10910783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).
    Oyomopito R; Lee MP; Phanuphak P; Lim PL; Ditangco R; Zhou J; Sirisanthana T; Chen YM; Pujari S; Kumarasamy N; Sungkanuparph S; Lee CK; Kamarulzaman A; Oka S; Zhang FJ; Mean CV; Merati T; Tau G; Smith J; Li PC;
    HIV Med; 2010 Sep; 11(8):519-29. PubMed ID: 20345881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy.
    Moore DM; Hogg RS; Yip B; Wood E; Tyndall M; Braitstein P; Montaner JS
    J Acquir Immune Defic Syndr; 2005 Nov; 40(3):288-93. PubMed ID: 16249702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A further investigation of health-related quality of life over time among men with HIV infection in the HAART era.
    Jia H; Uphold CR; Zheng Y; Wu S; Chen GJ; Findley K; Duncan PW
    Qual Life Res; 2007 Aug; 16(6):961-8. PubMed ID: 17468942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.